Liévens, J C <br/><br/>
Continuous administration of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylate produces striatal lesion.  [electronic resource] 

 -  Brain research. Molecular brain research  Oct 1997 
 - 181-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0169-328X 
<br/><br/><label>Standard No.: </label>10.1016/s0169-328x(97)00182-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Biological Transport<br/>Corpus Striatum--drug effects<br/>Dicarboxylic Acids--toxicity<br/>Dizocilpine Maleate--pharmacology<br/>Excitatory Amino Acid Antagonists--pharmacology<br/>Female<br/>Glutamic Acid--metabolism<br/>In Situ Hybridization<br/>Infusion Pumps, Implantable<br/>Molecular Weight<br/>Nerve Degeneration<br/>Neurotransmitter Uptake Inhibitors--toxicity<br/>Osmotic Pressure<br/>Pyrrolidines--toxicity<br/>Rats<br/>Rats, Wistar